ASO Targeting ZFP384 Sustains Microglial Repair Activity and Extends Stroke Recovery Window
核心洞察
Researchers identified the transcription factor ZFP384 (搜索) as a key regulator that diminishes microglial reparative functions after stroke (搜索), limiting the brain's spontaneous recovery window to approximately two months.
An antisense oligonucleotide (ASO) targeting Zfp384 (搜索) sustained microglial reparative activity, enhanced remyelination and neural plasticity, and improved functional recovery in mouse models even when administered weeks after injury.
Analysis of human brain tissue confirmed that the ZNF384 (搜索) orthologue shows an inverse relationship with the reparative factor IGF1, suggesting the mechanism is conserved in human stroke (搜索) recovery.
A collaborative research team led by Assistant Professor Jun Tsuyama and Professor Takashi Shichita from the Institute of Science Tokyo (搜索) has uncovered a molecular mechanism that governs the brain's limited capacity for spontaneous repair after stroke (搜索)—and demonstrated that an antisense oligonucleotide (ASO) can extend this recovery window, even when treatment begins weeks after injury. The findings, published in Nature on May 13, 2026, reveal a promising therapeutic strategy to reduce permanent neurological disability following stroke.
Stroke (搜索) remains one of the leading causes of long-term disability worldwide, frequently resulting in lasting impairments in movement, speech, and cognition. While the brain launches a coordinated repair program involving several cell types after injury, this intrinsic recovery capacity fades within approximately two months, leaving most patients with permanent neurological deficits. The molecular basis for this decline has remained poorly understood—until now.
Uncovering the ZFP384 (搜索) Brake on Repair
The researchers focused on microglia, the brain's resident immune cells that play a pivotal role in post-stroke (搜索) recovery. Immediately after injury, microglia trigger inflammation but then rapidly transition into a reparative state, producing growth factors such as insulin-like growth factor 1 (IGF1) that support remyelination, strengthen neural connections, and promote functional recovery. However, this reparative activity is not sustained.
"We aimed to identify the molecular mechanism responsible for diminishing microglial reparative functions," explained Tsuyama.
The team identified a specific transcription factor, ZFP384 (搜索), whose expression increases as the brain's spontaneous repair functions diminish. Mechanistically, ZFP384 disrupts chromatin interactions mediated by the protein YY1 that are necessary for gene expression associated with neural repair. Consequently, microglia lose their reparative properties despite the brain's ongoing recovery needs.
Genetic Deletion Confirms the Mechanism
To validate the role of ZFP384 (搜索), the researchers genetically deleted the Zfp384 gene specifically from microglia in mouse models of stroke (搜索). These animals maintained recovery-associated gene expression for a significantly longer period than normal mice. Sustaining the reparative state of microglia enhanced remyelination of damaged nerve fibers and promoted synaptic plasticity, resulting in significantly better long-term neurological function.
ASO Therapy Extends the Recovery Window
Building on these genetic findings, the team developed a therapeutic antisense oligonucleotide—ASO-Zfp384 (搜索)—designed to suppress Zfp384 (搜索) expression. Remarkably, the treatment sustained microglial reparative functions and remained therapeutic even when administered one week or one month after stroke (搜索) onset. Rather than simply reducing inflammation, the ASO helped retain the brain's own reparative program, enhancing post-stroke recovery from neurological deficits.
"By identifying the mechanism that diminishes the brain's intrinsic recovery functions, we looked for a potential way to preserve its spontaneous recovery," noted Tsuyama.
Human Relevance Confirmed
The team also examined brain tissues from patients who had experienced a stroke (搜索) and found evidence that the mechanism operates in humans. Similar to observations in mice, the expression of ZNF384 (搜索) in humans—an orthologue of murine ZFP384 (搜索)—increased as the reparative factor IGF1 declined, revealing an inverse relationship. This suggests that the molecular pathway identified in mice is relevant to human stroke recovery and could represent a viable therapeutic target.
A Paradigm Shift in Organ Repair
Beyond stroke (搜索), the study introduces a broader conceptual framework for promoting endogenous recovery mechanisms after organ injury. Rather than attempting to replace damaged tissue, preserving and prolonging the body's own repair mechanisms may hold the key to more successful treatments.
"Based on our findings, sustaining the brain's endogenous repair program creates new opportunities to decrease permanent neurological symptoms during the rehabilitation phase," added Tsuyama.
The researchers will now focus on evaluating the safety and efficacy of ZFP384 (搜索)-targeting therapies in larger preclinical models and ultimately in clinical trials. If successful, this approach could enhance functional recovery from post-stroke (搜索) neurological deficits by extending the brain's spontaneous recovery window, reducing the burden of stroke-related disability.
The study was conducted in collaboration with researchers from the Tokyo Metropolitan Institute of Medical Science, Kyushu University, and the University of Freiburg in Germany.